BIOLASE INC (BIOL)

US0909117022 - Common Stock

0.148  0 (0%)

After market: 0.148 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
49.16M48.46M39.19M22.78M37.80M
Cost Of Goods
32.44M32.55M22.66M16.61M23.51M
Gross Profit
16.72M15.91M16.53M6.17M14.29M
Operating Expenses
34.66M41.25M32.65M24.71M29.91M
Research and Development
6.00M7.27M6.05M3.70M4.77M
Selling, General, and Administrative Expenses
28.66M33.98M26.60M21.01M25.14M
Operating Income
-17.94M-25.34M-16.12M-18.54M-15.62M
Interest Income/Expense
-2.71M-3.19M-2.68M-2.38M-2.28M
Other Income/Expense
48.00KN/A0.004.22MN/A
Non Recurring Items
0.000.002.70M0.000.00
Income Before Taxes
-20.60M-28.53M-16.09M-16.70M-17.90M
Income Tax
31.00K110.00K70.00K130.00K-40.00K
Net Income
-37.62M-28.85M-16.70M-34.21M-17.86M
EBITDA
-15.14M-24.84M-15.72M-18.04M-14.64M
 
Per Share Data
EPS Diluted Total Ops
-29.44-412.14-278.33-1.71K-1.79K
Non GAAP EPS
-31.89-410.00-3.25-8.75-11.25
 
Statistics
Gross Profit Margin
34.02%32.83%42.18%27.09%37.80%
Profit Margin
-76.52%-59.53%-42.61%-150.18%-47.25%
Operating Profit Margin
-36.48%-52.29%-41.13%-81.39%-41.32%

All data in USD

Charts